Skip to content

Gleevec

Imatinib

Designed to support neoplastic cellular control to manage myeloid leukaemia and alleviate tumour tissue progression.

Active ingredient
Imatinib
Route
Oral use
Form
Tablet
Strengths
400mg

You will receive a quality generic equivalent of Gleevec, depending on stock.

Prescription and consultation requirements for Gleevec vary by destination and are determined by the fulfilment partner.

Gleevec details

Alternative names
imatinib
Therapeutic class
Tyrosine Kinase Inhibitor
Pharmacological class
Antineoplastic
Contraindications
severe hypersensitivity to imatinib
Minor side effects
nausea; vomiting; diarrhoea
Moderate side effects
fluid retention; muscle cramps; fatigue
Dosage forms
Tablet
Administration route
Oral use
Supply category
Prescription-only medicine (POM)
Originator
Novartis
Onset Time
1–2 weeks
Duration
24 hours
Storage instructions
Store below 25°C.
Drug interactions
Ketoconazole; Rifampin; Warfarin
Age restrictions
Approved for paediatric and adult populations.
Serious side effects

severe hepatotoxicity, requires immediate medical attention; severe bone marrow suppression, requires immediate medical attention

Patient summary

designed to support neoplastic cellular control to manage myeloid leukaemia and alleviate tumour tissue progression.

Mechanism of action

Inhibits the Bcr-Abl tyrosine kinase enzyme, halting signaling pathways that trigger neoplastic cellular proliferation.

Pregnancy and breastfeeding

TGA Category D: High risk of fetal toxicity. Do not use during pregnancy. Breastfeeding: Avoid.

What you will receive

Gleevec is the originator brand name, made by Novartis. We use it to identify the medicine and are not affiliated with Novartis.

  • The fulfilment partner confirms whether the exact brand or an equivalent containing Imatinib is offered.
  • The offered brand, manufacturer and dispatch location depend on the product, destination and partner warehouse.
  • Check the final product details at checkout before confirming an order.

How we compare medicine brands and generics